» Articles » PMID: 20393144

E-cadherin Expression is Regulated by MiR-192/215 by a Mechanism That is Independent of the Profibrotic Effects of Transforming Growth Factor-beta

Overview
Journal Diabetes
Specialty Endocrinology
Date 2010 Apr 16
PMID 20393144
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Increased deposition of extracellular matrix (ECM) within the kidney is driven by profibrotic mediators including transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF). We investigated whether some of their effects may be mediated through changes in expression of certain microRNAs (miRNAs).

Research Design And Methods: Proximal tubular cells, primary rat mesangial cells, and human podocytes were analyzed for changes in the expression of key genes, ECM proteins, and miRNA after exposure to TGF-beta (1-10 ng/microl). Tubular cells were also infected with CTGF-adenovirus. Kidneys from diabetic apoE mice were also analyzed for changes in gene expression and miRNA levels.

Results: TGF-beta treatment was associated with morphologic and phenotypic changes typical of epithelial-mesenchymal transition (EMT) including increased fibrogenesis in all renal cell types and decreased E-cadherin expression in tubular cells. TGF-beta treatment also modulated the expression of certain miRNAs, including decreased expression of miR-192/215 in tubular cells, mesangial cells, which are also decreased in diabetic kidney. Ectopic expression of miR-192/215 increased E-cadherin levels via repressed translation of ZEB2 mRNA, in the presence and absence of TGF-beta, as demonstrated by a ZEB2 3'-untranslated region luciferase reporter assay. However, ectopic expression of miR-192/215 did not affect the expression of matrix proteins or their induction by TGF-beta. In contrast, CTGF increased miR-192/215 levels, causing a decrease in ZEB2, and consequently increased E-cadherin mRNA.

Conclusions: These data demonstrate the linking role of miRNA-192/215 and ZEB2 in TGF-beta/CTGF-mediated changes in E-cadherin expression. These changes appear to occur independently of augmentation of matrix protein synthesis, suggesting that a multistep EMT program is not necessary for fibrogenesis to occur.

Citing Articles

MicroRNAs in diabetes mellitus.

Shaik Syed Ali P, Ahmad M, Parveen K J Diabetes Metab Disord. 2025; 24(1):77.

PMID: 40060270 PMC: 11885724. DOI: 10.1007/s40200-025-01591-y.


An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.

Alqabandi J, David R, Abdel-Motal U, ElAbd R, Youcef-Toumi K Sci Rep. 2024; 14(1):30107.

PMID: 39627312 PMC: 11615046. DOI: 10.1038/s41598-024-79154-z.


Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers.

Anuradha U, Mehra N, Khatri D Mol Biol Rep. 2024; 51(1):82.

PMID: 38183502 DOI: 10.1007/s11033-023-09074-0.


SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy.

Wang Y, Liu T, Cai Y, Liu W, Guo J Front Endocrinol (Lausanne). 2023; 14:1244705.

PMID: 37876546 PMC: 10591331. DOI: 10.3389/fendo.2023.1244705.


Capturing the Kidney Transcriptome by Urinary Extracellular Vesicles-From Pre-Analytical Obstacles to Biomarker Research.

Barreiro K, Dwivedi O, Rannikko A, Holthofer H, Tuomi T, Groop P Genes (Basel). 2023; 14(7).

PMID: 37510317 PMC: 10379145. DOI: 10.3390/genes14071415.


References
1.
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E . The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7(6):1267-78. DOI: 10.1016/s1097-2765(01)00260-x. View

2.
Braun C, Zhang X, Savelyeva I, Wolff S, Moll U, Schepeler T . p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008; 68(24):10094-104. PMC: 2836584. DOI: 10.1158/0008-5472.CAN-08-1569. View

3.
Krupa A, Jenkins R, Luo D, Lewis A, Phillips A, Fraser D . Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol. 2010; 21(3):438-47. PMC: 2831862. DOI: 10.1681/ASN.2009050530. View

4.
Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

5.
Korpal M, Lee E, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008; 283(22):14910-4. PMC: 3258899. DOI: 10.1074/jbc.C800074200. View